Boston Scientific Sees 2024 Adjusted EPS Of $2.29-$2.34 Versus Prior Guidance Of $2.23-$2.27 Versus Consensus Of $2.25
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific has updated its 2024 adjusted EPS guidance to $2.29-$2.34, an increase from the previous guidance of $2.23-$2.27, and above the consensus estimate of $2.25.
April 24, 2024 | 10:38 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific has raised its 2024 adjusted EPS guidance to a range of $2.29-$2.34, exceeding both its previous forecast and analyst consensus.
Raising EPS guidance typically signals a company's confidence in its future profitability, which can positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100